Brain metastases in metastatic breast cancer: prevalence per line of treatment and cumulative incidence in a cohort of 18075 real-world patients

被引:0
|
作者
Sammons, Sarah
Leone, Jose
Lambert, Thibaut Sanglier Peter
Montemurro, Filippo
Poppe, Raf
Restuccia, Eleonora
Tolaney, Sara
Lin, Nancy
机构
关键词
D O I
10.1158/1538-7445.SABCS23-PS11-01
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PS11-01
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Gender differences in treatment allocation and survival in a real-world metastatic pancreatic cancer cohort
    Pijnappel, E.
    Schuurman, M.
    Wagner, A. D.
    De Vos-Geelen, J.
    Van der Geest, L.
    De Groot, J. W. B.
    Koerkamp, B. Groot
    De Hingh, I.
    Homs, M.
    Creemers, G-J.
    Cirkel, G.
    Van Sanvoort, H.
    Busch, O.
    Besselink, M.
    Van Eijck, C.
    Wilmink, H.
    Van Laarhoven, H.
    ANNALS OF ONCOLOGY, 2021, 32 : S1089 - S1089
  • [42] Real-world clinical outcomes in US patients with brain metastases secondary to HR+/HER2-metastatic breast cancer treated with abemaciclib
    Gathirua-Mwangi, Wambui
    Martin, Holly
    He, Dan
    Zheng, Shen
    Sheffield, Kristin
    John, Jincy
    Rybowski, Sarah
    Brastianos, Priscilla
    CANCER RESEARCH, 2024, 84 (09)
  • [43] Efficacy of Ipilimumab and Nivolumab in Patients with Melanoma and Brain Metastases-A Danish Real-World Cohort
    Kattenhoj, Karoline Dreyer
    Moberg, Christine Louise
    Guldbrandt, Louise Mahncke
    Friis, Rasmus Blechingberg
    Mapendano, Christophe Kamungu
    Petersen, Soren Kjaer
    Ruhlmann, Christina Halgaard Bruvik
    Svane, Inge Marie
    Donia, Marco
    Ellebaek, Eva
    Schmidt, Henrik
    CANCERS, 2024, 16 (14)
  • [44] A real-world study: third-line treatment options for metastatic colorectal cancer
    Wu, Chen
    Li, Shuai
    Hou, Xinfang
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [45] Incidence of brain Metastases in a cohort of patients with breast, colon, kidney, and lung cancer, and melanoma
    Schouten, LJ
    Rutten, J
    Huveneers, HA
    Twijnstra, A
    NEUROLOGY, 2002, 58 (07) : A49 - A49
  • [46] Management of Patients with Brain Metastases Receiving Trastuzumab Treatment for Metastatic Breast Cancer
    Witzela, Isabell
    Kantelhardt, Eva Johanna
    Milde-Langosch, Karin
    Ihnen, Maike
    Zeitz, Julia
    Harbeck, Nadia
    Jaenicke, Fritz
    Mueller, Volkmar
    ONKOLOGIE, 2011, 34 (06): : 304 - 308
  • [47] Etirinotecan Pegol Treatment for Patients With Metastatic Breast Cancer and Brain Metastases Reply
    Tripathy, Debu
    Tolaney, Sara M.
    Tagliaferri, Mary
    JAMA ONCOLOGY, 2022, 8 (11) : 1700 - 1701
  • [48] Elucidating Determinants of Survival Disparities Among a Real-world Cohort of Metastatic Breast Cancer Patients: A National Cancer Database Analysis
    Statler, Abby B.
    Wei, Wei
    Gupta, Annie
    Blake, Cassann N.
    Hobbs, Brian P.
    Nahleh, Zeina A.
    CLINICAL BREAST CANCER, 2020, 20 (05) : E625 - E650
  • [49] Characterization of the immune landscape of primary vs metastatic breast cancer in a real-world data cohort
    Chhibber, Aparna
    Braun, Kim Van Naarden
    Han, Celine
    Chang, Han
    Roberts, Mustimbo
    Li, Bin
    CANCER RESEARCH, 2022, 82 (04)
  • [50] Real World Data for Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases
    Toler, Andrew
    Bobolts, Laura R.
    Mangurian, Mark
    Pozotrigo, Melissa
    Wise, Corey
    Solomon, Hiywete
    Hartung, Nicole
    Makielski, Rory
    Marur, Shika
    Ravindranathan, Meera
    Marur, Shanthi
    CANCER RESEARCH, 2023, 83 (05)